The device joins a portfolio of vascular technologies that generated 9.5% sales growth on a comparable basis in the first quarter.
Abbott gets FDA nod, CE mark for AI-enabled imaging device
<figure><div><img src="https://imgproxy.divecdn.com/otXKWk5IW410v1ZEZBVedv94wFthlU3Q4SfgVjYEJaQ/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9XQkE4ODEuanBn.webp"/></div></figure><p>The device joins a portfolio of vascular technologies that generated 9.5% sales growth on a comparable basis in the first quarter.</p>

Source: MedTech Dive